Compare SRAD & EMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRAD | EMN |
|---|---|---|
| Founded | 2001 | 1920 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Major Chemicals |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 8.0B |
| IPO Year | 2021 | 1996 |
| Metric | SRAD | EMN |
|---|---|---|
| Price | $18.00 | $67.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 14 |
| Target Price | $30.18 | ★ $78.57 |
| AVG Volume (30 Days) | ★ 2.1M | 1.3M |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | N/A | ★ 4.96% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.10 |
| Revenue | N/A | ★ $8,752,000,000.00 |
| Revenue This Year | $24.65 | $1.75 |
| Revenue Next Year | $15.05 | $3.32 |
| P/E Ratio | $49.48 | ★ $16.49 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.73 | $56.11 |
| 52 Week High | $32.22 | $92.19 |
| Indicator | SRAD | EMN |
|---|---|---|
| Relative Strength Index (RSI) | 47.57 | 30.78 |
| Support Level | $16.21 | $66.44 |
| Resistance Level | $19.67 | $70.51 |
| Average True Range (ATR) | 0.88 | 2.73 |
| MACD | 0.13 | -1.32 |
| Stochastic Oscillator | 45.12 | 5.31 |
Sportradar Group AG is a technology platform enabling next-generation engagement in sports, and a provider of B2B solutions to the sports betting industry. It generates revenue through two primary sources: subscription-based revenue and revenue sharing. Geographically, it operates in North America, Africa, AsiaPac & Middle East, Europe, and LATAM & Caribbean.
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.